WallStreetZenWallStreetZen

NASDAQ: WINT
Windtree Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for WINT

Based on 1 analyst offering 12 month price targets for Windtree Therapeutics Inc

Min Forecast
$7.00+1,791.89%
Avg Forecast
$7.00+1,791.89%
Max Forecast
$7.00+1,791.89%

Should I buy or sell WINT stock?

Based on 1 analyst offering ratings for Windtree Therapeutics Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their WINT stock forecasts and price targets.

WINT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-12-04

1 of 1

Forecast return on equity

Is WINT forecast to generate an efficient return?

Company
N/A
Industry
14,374.93%
Market
325.1%

Forecast return on assets

Is WINT forecast to generate an efficient return on assets?

Company
N/A
Industry
5,869.59%

WINT earnings per share forecast

What is WINT's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$5.66
Avg 2 year Forecast
-$2.86

WINT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
WINT$0.37$7.00+1,791.89%Hold
XRTX$1.15N/AN/A
THAR$2.25$17.00+655.56%Strong Buy
QLGN$4.48N/AN/A
PCSA$1.03$6.00+480.83%Buy
View Top Biotech Stocks

Windtree Therapeutics Stock Forecast FAQ

Is Windtree Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: WINT) stock is to Hold WINT stock.

Out of 1 analyst, 0 (0%) are recommending WINT as a Strong Buy, 0 (0%) are recommending WINT as a Buy, 1 (100%) are recommending WINT as a Hold, 0 (0%) are recommending WINT as a Sell, and 0 (0%) are recommending WINT as a Strong Sell.

If you're new to stock investing, here's how to buy Windtree Therapeutics stock.

What is WINT's earnings growth forecast for 2024-2025?

(NASDAQ: WINT) Windtree Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.39%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.94%.

Windtree Therapeutics's earnings in 2024 is -$10,709,000.On average, 1 Wall Street analyst forecast WINT's earnings for 2024 to be -$50,882,426, with the lowest WINT earnings forecast at -$50,882,426, and the highest WINT earnings forecast at -$50,882,426.

In 2025, WINT is forecast to generate -$25,710,908 in earnings, with the lowest earnings forecast at -$25,710,908 and the highest earnings forecast at -$25,710,908.

What is WINT's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: WINT) forecast ROE is N/A, which is considered weak.

What is WINT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year WINT price target, the average WINT price target is $7.00, with the highest WINT stock price forecast at $7.00 and the lowest WINT stock price forecast at $7.00.

The Wall Street analyst predicted that Windtree Therapeutics's share price could reach $7.00 by Dec 4, 2025. The average Windtree Therapeutics stock price prediction forecasts a potential upside of 1,791.89% from the current WINT share price of $0.37.

What is WINT's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: WINT) Windtree Therapeutics's current Earnings Per Share (EPS) is -$16.48. On average, analysts forecast that WINT's EPS will be -$5.66 for 2024, with the lowest EPS forecast at -$5.66, and the highest EPS forecast at -$5.66. In 2025, WINT's EPS is forecast to hit -$2.86 (min: -$2.86, max: -$2.86).

What is WINT's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: WINT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 5,869.59%.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.